已收盘 10-31 16:00:00 美东时间
+0.570
+0.53%
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25
Wells Fargo analyst Zachary Fadem maintains Brinker International (NYSE:EAT) with a Overweight and lowers the price target from $175 to $160.
10-30 22:20
华盛资讯10月30日讯,BRINKER INTERNATIONAL, INC公司今日公布2025财年Q3业绩,公司Q3营收13.49亿美元,同比增长18.5%,股权持有人应占溢利1.00亿美元,同比增长158.4%。
10-30 10:19
Brinker International (EAT) reported Q1 results above expectations with earnings of $1.93 per share and revenue of $1.35 billion. Chili's sales rose 21% and Maggiano's saw a decline.
10-29 21:51
Companies Reporting Before The Bell • OppFi (NYSE:OPFI) is expected to report q...
10-29 19:11
Brinker International (NYSE:EAT) traded higher in early action on Wednesday after topping analyst expectations with its fiscal first-quarter earnings report. Revenue was up 19.5% year-over-year to $1....
10-29 18:58
Brinker International (NYSE:EAT) affirms FY2026 Adj EPS guidance from $9.90-$10.50 to $9.90-$10.50 vs $10.39 analyst estimate. Affirms FY2026 sales outlook from $5.600 billion-$5.700 billion to $5.600 billion-$5.700
10-29 18:47
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
10-29 09:25
An update from EAT&HOLDINGS Co., Ltd. ( ($JP:2882) ) is now available. EAT&...
10-28 12:22
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
10-28 10:08